Clinical Trial Update: Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis

View source ↗

Summary

A completed clinical trial explored the role of epidermal growth factor in the development of necrotizing enterocolitis, particularly in the context of prematur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis
• Premature Birth

Drugs mentioned

• Epidermal Growth Factor (epidermal growth factor)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Necrotizing Enterocolitis, Premature Birth | Status: COMPLETED